IL10 and ulcerative colitis: Also, it has been shown that the abundance of Fusicatenibacter saccharivorans decreases in patients with active ulcerative colitis, but increases in patients with quiescent ulcerative colitis, and the bacterium suppresses intestinal inflammation through IL-10 secretion (Takeshita et al., 2016).